ATLASArriVent BioPharma (AVBP) earnings date: Nov 9, 2026
ArriVent BioPharma (AVBP) reports earnings for the quarter ended Sep 30, 2026 on Mon, Nov 9, 2026. Analysts expect EPS of -$1.04.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on AVBP
| Last price | $13.33 (-10.4%) |
|---|---|
| Normal 1-day range (±1σ) | ±9.6% |
| Earnings beat history | Beat the EPS estimate in 2 of the last 5 reports |
These figures come from the same calibrated model and valuation as the ArriVent BioPharma stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
ArriVent BioPharma reports on Nov 9, 2026. One email the day before, with ATLAS’s read on ArriVent BioPharma. You can switch it off at any time.
Alert me before AVBP reportsFree to start. Creating an account takes under a minute.
Notify me when ArriVent BioPharma reports
Track AVBP free Add ArriVent BioPharma to a free ATLAS watchlist and see its next report date in one place.
AVBP earnings at a glance
| Next report (confirmed) | Mon, Nov 9, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$1.04 |
| Last report | Aug 12, 2026 · Miss |
| Beat rate (last 5 reports) | 2 of 5 (40%) |
| Average EPS surprise | -1.4% |
| Average move around a report | ±5.7% (last 5) |
| Sector | Healthcare · Biotechnology |
ArriVent BioPharma earnings history: last 5 reports
ArriVent BioPharma last reported on Aug 12, 2026: EPS of -$1.05 against an estimate of -$0.98 (-7.1% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 12, 2026 | -$0.98 | -$1.05 | -7.1% | Miss | -4.4% |
| May 20, 2026 | $2.91 | $3.09 | +6.2% | Beat | +3.3% |
| May 11, 2026 | -$0.89 | -$0.96 | -7.9% | Miss | -1.8% |
| Mar 5, 2026 | -$0.85 | -$0.78 | +8.2% | Beat | -11.8% |
| Nov 10, 2025 | -$0.78 | -$0.83 | -6.4% | Miss | +7.4% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for AVBP
See the fair value, the probability range and the earnings history of ArriVent BioPharma on its ATLAS page.
ArriVent BioPharma (AVBP) stock analysisPlans from €3.99 a month.
ArriVent BioPharma earnings: frequently asked questions
When does ArriVent BioPharma (AVBP) report earnings?
ArriVent BioPharma is scheduled to report on Monday, November 9, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for AVBP?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$1.04 per share (USD). Estimates can change before the report.
How often does AVBP beat earnings estimates?
Of its last 5 reports with a recorded result, ArriVent BioPharma beat the EPS estimate 2 times; the average surprise was -1.4%. Past results do not predict the next one.
How much does AVBP move around earnings?
Over its last 5 reports the stock moved an average of 5.7% (absolute, from the close before the report day to the close after it), and finished higher 2 of 5 times.
Did ArriVent BioPharma beat earnings estimates last quarter?
ArriVent BioPharma last reported on Aug 12, 2026: EPS of -$1.05 against an estimate of -$0.98 (-7.1% surprise), a miss.
How much does AVBP usually move in a day?
On a normal trading day the ATLAS model puts AVBP’s one-day range at about ±9.6%, with a 48% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Mon, Nov 9, 2026
Educational information, not investment advice. Disclaimer